$BDPT....I like this!!
>>The reason people are investing in this biotech stock is not solely based on its current offerings but rather the immense potential it holds. With a series of anticipated news and press releases during the month March and April, along with the addition of new board members, licensing agreements for innovative products with patents valued at over $750 million, and upcoming spin-off plans, there is a significant buzz around the company. Additionally, the company's connection to artificial intelligence further adds to its allure. >>>